Pharmaceuticals
From prevention to treatment, Meiji is improving the quality of care and lowering drug costs for millions of patients worldwide.
Pharmaceuticals
From prevention to treatment, Meiji is improving the quality of care and lowering drug costs for millions of patients worldwide.
Pharmaceuticals
From prevention to treatment, Meiji is improving the quality of care and lowering drug costs for millions of patients worldwide.
Areas of Focus
Innovation at Meiji
Our Business
Medical needs are constantly evolving, and Meiji is responding through the development of new drugs for infectious diseases and other conditions. We also engage in open innovation in fields such as hematology and oncology.
Medical
New Drug
Development
Hematology
Oncology
Biosimilars
Pipeline
Blood tumors
Latest News
PHARMACEUTICALS
Announcement of the Establishment of Local Subsidiary "Meiji Pharma Asia Pte. Ltd." in Singapore
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan, President and Representative Director: Toshiaki Nagasato) announced the establishment of a local subsidiary, “Meiji Pharma Asia Pte. Ltd.” (Headquarters: Singapore, Managing Director: Kensuke Hata) in Singapore on December 10th.


